Quantum dot light-emitting layer, quantum dot light-emitting device and preparing methods therefor
US-2020013976-A1 · Jan 9, 2020 · US
US10808172B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10808172-B2 |
| Application number | US-201916566903-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 11, 2019 |
| Priority date | Jan 31, 2019 |
| Publication date | Oct 20, 2020 |
| Grant date | Oct 20, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A perovskite luminescent nanocrystal has a chemical formula represented by: Cs 4 BX 6 , wherein B includes one or more selected from the group consisting of Ge, Pb, Sn, Sb, Bi, Cu, and Mn, and X includes one or more selected from the group consisting of Cl, Br, and I, wherein the Cs 4 BX 6 perovskite luminescent nanocrystal has a pure phase, and a molar ratio of Cs to B (Cs/B) in the Cs 4 BX 6 perovskite luminescent nanocrystal is greater than 1 and less than 4.
Opening claim text (preview).
What is claimed is: 1. A perovskite luminescent nanocrystal represented by a chemical formula of: Cs 4 BX 6 , wherein B comprises one or more selected from the group consisting of Ge, Pb, Sn, Sb, Bi, Cu, and Mn, and X comprises one or more selected from the group consisting of Cl, Br, and I, wherein the Cs 4 BX 6 perovskite luminescent nanocrystal has a pure phase, and a molar ratio of Cs to B (Cs/B) in the Cs 4 BX 6 perovskite luminescent nanocrystal is greater than 1 and less than 4. 2. The perovskite luminescent nanocrystal of claim 1 , wherein a size of the perovskite luminescent nanocrystal is smaller than 500 nm. 3. A light emitting device comprising: a light emitting element configured to emit blue light or ultraviolet light; and a light emitting material, wherein the light emitting material comprises the perovskite luminescent nanocrystal of claim 1 , and the light emitting material is excited by the blue light or the ultraviolet light to emit first light rays. 4. The light emitting device of claim 3 , wherein when the perovskite luminescent nanocrystal is Cs 4 PbBr 6 , the first light rays have a peak wavelength ranged from 500 nm to 540 nm and an FWHM ranged from 10 nm to 30 nm. 5. The light emitting device of claim 3 , wherein the light emitting material further comprises one or more other wavelength converting materials. 6. The light emitting device of claim 5 , wherein the one or more wavelength converting materials are excited by the blue light or the ultraviolet light to emit second light rays. 7. The light emitting device of claim 6 , wherein a peak wavelength of the second light rays fall within a red wavelength range. 8. The light emitting device of claim 3 , wherein the light emitting element is a light emitting diode chip, a sub-millimeter light emitting diode chip, or a micro light emitting diode chip. 9. A manufacturing method for a perovskite luminescent nanocrystal comprising steps of: forming a cesium (Cs)-containing oleic acid precursor; mixing the cesium-containing oleic acid precursor, a non-polar solvent, and a first nucleating agent to form a first solution; adding BX 2 , a polar solvent, and a second nucleating agent to the first solution to form a second solution, wherein B comprises one or more selected from the group consisting of Ge, Pb, Sn, Sb, Bi, Cu, and Mn, and X comprises one or more selected from the group consisting of Cl, Br, and I; and stirring the second solution to form a perovskite luminescent nanocrystal represented by a chemical formula of: Cs 4 BX 6 , wherein B comprises one or more selected from the group consisting of Ge, Pb, Sn, Sb, Bi, Cu, and Mn, and X comprises one or more selected from the group consisting of Cl, Br, and I, wherein the Cs 4 BX 6 perovskite luminescent nanocrystal has a pure phase, and a molar ratio of Cs to B (Cs/B) in the Cs 4 BX 6 perovskite luminescent nanocrystal is greater than 1 and less than 4 by using an elemental analysis. 10. The manufacturing method of claim 9 , wherein the step of forming the cesium oleate precursor comprises: dissolving a cesium-containing precursor in oleic acid, wherein the cesium-containing precursor comprises cesium carbonate, cesium bromide, cesium oleylamine, or cesium oleate. 11. The manufacturing method of claim 9 , wherein the second solution is stirred in a nitrogen condition at a room temperature to form the perovskite luminescent nanocrystal. 12. The manufacturing method of claim 9 , wherein the step of forming the second solution further comprises adding a solubilizing agent, and the solubilizing agent is HX, wherein X is F, Cl, Br, or I. 13. The manufacturing method of claim 9 , wherein each of the first nucleating agent and the second nucleating agent comprises oleic acid, oleylamine, or a combination thereof. 14. The manufacturing method of claim 9 , wherein a polarity difference between the polar solvent and the non-polar solvent is greater than or equal to 3 and less than or equal to 10. 15. The manufacturing method of claim 14 , wherein when the polarity difference between the polar solvent and the non-polar solvent is greater than or equal to 3 and less than 6, the perovskite luminescent nanocrystal has a particle size between 100 nm and 500 nm is formed. 16. The manufacturing method of claim 14 , wherein when the polarity difference between the polar solvent and the non-polar solvent is greater than or equal to 6 and less than or equal to 10, the perovskite luminescent nanocrystal has a particle size between 10 nm and 100 nm is formed. 17. The manufacturing method of claim 9 , wherein the polar solvent is selected from the group consisting of isopropanol, Isobutyl alcohol, tetrafuran, water, acetone, methanol, ethanol, ethylene glycol, n-propanol, n-butanol, ethyl acetate, acetonitrile, dimethyl formamide, and dimethyl sulfoxide, and the non-polar solvent is selected from the group consisting of n-pentane, hexane, cyclohexane, benzene, toluene, p-xylene, and chlorobenzene. 18. The manufacturing method of claim 9 , wherein the elemental analysis comprises an energy-dispersive X-ray spectroscopy measurement, an inductively coupled plasma atomic emission spectroscopy measurement, or an inductively coupled plasma mass spectrometry measurement.
of wavelength conversion means · CPC title
Wavelength conversion materials · CPC title
having two or more wavelength conversion materials · CPC title
Compounds containing lead, with or without oxygen or hydrogen, and containing two or more other elements · CPC title
Nanometer sized, i.e. from 1-100 nanometer · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.